Dyadic International Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.90

+0.02 (+1.82%)

As of Jun 30, 10:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,542.9% upside

Low Target $20.70

Average Target $32.64

High Target $34.69

Current Price $0.90

Current
$0.90

Target
$32.64

$20.70 $32.64 avg $34.69

Scenario Analysis

Bear Case

$20.70

2,210.3%

Low target

Base Case

$32.64

+3,542.9%

Avg target

Bull Case

$34.69

+3,771.7%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.35

-33.4% from high

52-Week Low

$0.65

+36.9% from low

Target vs 52W High

$32.64

+2,325.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%